Online citations, reference lists, and bibliographies.
← Back to Search

Adult Craniopharyngiomas: Differences And Lessons From Paediatrics

E. Jouanneau, G. Raverot, P. Wertheimer, Joseph Jules Francois, Felix Babinski
Published 2020 ·

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
Endoscopic cranial base surgery: ready for prime time?
D. Prevedello (2007)
10.1227/01.NEU.0000156788.44397.B4
Monitoring the Expression Profiles of Integrins and Adhesion/Growth-regulatory Galectins in Adamantinomatous Craniopharyngiomas: Their Ability to Regulate Tumor Adhesiveness to Surrounding Tissue and Their Contribution to Prognosis
F. Lefranc (2005)
10.1038/nature00766
Mutations of the BRAF gene in human cancer
Helen Davies (2002)
10.3171/2018.5.JNS18153
Harvey Cushing's craniopharyngioma treatment: Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor.
J. M. Pascual (2018)
10.1002/cncr.22633
Intracystic bleomycin therapy for craniopharyngioma in children
J. Hukin (2007)
The classification of tumours of the central nervous system.
R. O. Barnard (1982)
10.1007/s11064-011-0560-9
Expression of Matrix Metalloproteinase-9, Type IV Collagen and Vascular Endothelial Growth Factor in Adamantinous Craniopharyngioma
Z. Xia (2011)
10.3171/2014.2.FOCUS13567
Development of intracranial approaches for craniopharyngiomas: an analysis of the first 160 historical procedures.
José M Pascual (2014)
10.2500/105065800782102771
Pneumatization of the Sphenoid Sinus in Children Evaluated by Magnetic Resonance Imaging
Y. J. Jang (2000)
10.1210/jc.2012-2069
Xanthogranuloma, Rathke's cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations.
H. Müller (2012)
10.3171/FOC.2005.19.1.9
Evolution of reconstructive techniques following endoscopic expanded endonasal approaches.
A. Kassam (2005)
10.1159/000120871
Surgical management of recurrent craniopharyngiomas.
J. Wisoff (1994)
10.1227/00006123-199206000-00028
Modified supraorbital craniotomy: technical note.
J. Delashaw (1992)
10.1159/000318426
Endocrinological Outcomes of Pediatric Craniopharyngiomas with Anatomical Pituitary Stalk Preservation: Preliminary Study
T. Jung (2010)
10.1007/s11102-018-0909-z
BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series
Emanuele La Corte (2018)
10.1159/000446072
Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma
C. Chang (2016)
Rehabilitation jugendlicher Kraniopharyngeom-Patienten
T Flick (1986)
10.1097/00005792-197507000-00002
MANIFESTATIONS OF HYPOTHALAMIC OBESITY IN MAN: A COMPREHENSIVE INVESTIGATION OF EIGHT PATIENTS AND A EEVIEW OF THE LITERATURE
G. Bray (1975)
10.3171/2017.6.FOCUS17256
The hypothalamus at the crossroads of psychopathology and neurosurgery.
D. A. Barbosa (2017)
10.3171/JNS.2002.97.SUPPLEMENT
Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients.
E. Ulfarsson (2002)
10.1210/JC.2004-0667
Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
M. Geffner (2004)
10.1227/NEU.0b013e31822e8ffc
Endoscopic, Endonasal Resection of Craniopharyngiomas: Analysis of Outcome Including Extent of Resection, Cerebrospinal Fluid Leak, Return to Preoperative Productivity, and Body Mass Index
L. Leng (2012)
10.3928/0191-3913-19970701-09
Visual outcome of craniopharyngioma in children.
L. Abrams (1997)
Radiation therapy in the management of craniopharyngioma: current concepts and future developments.
J. Habrand (2006)
10.4158/EP14541.DSCR
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE MANAGEMENT FOLLOWING PITUITARY SURGERY.
W. Woodmansee (2015)
[Treatment of craniopharyngiomas in children. Retrospective analysis of 50 cases].
A. Pierre-Kahn (1988)
10.1007/BF00302222
Neurological and behavioral sequelae following different approaches to craniopharyngioma
M. Colangelo (2004)
10.1515/jpem-2014-0512
Hypothalamic obesity in children: pathophysiology to clinical management
B. Haliloǧlu (2015)
10.1055/s-0032-1304834
Side-cutting aspiration device for endoscopic and microscopic tumor removal.
N. Mclaughlin (2012)
10.2217/cns-2016-0034
BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors.
A. Roque (2017)
10.1002/cne.22283
Paraventricular hypothalamic nucleus: Axonal projections to the brainstem
Joel C Geerling (2010)
A biography
Jf Harvey Fulton (1946)
10.1007/s11102-008-0165-8
Craniopharyngioma: historical notes
J. Lindholm (2008)
10.1186/1741-7007-11-27
The buccohypophyseal canal is an ancestral vertebrate trait maintained by modulation in sonic hedgehog signaling
R. Khonsari (2012)
10.2478/raon-2013-0036
Early outcome in endoscopic extended endonasal approach for removal of supradiaphragmatic craniopharyngiomas: a case series and a comprehensive review
R. Bosnjak (2013)
10.1111/j.1365-2265.2010.03838.x
Morbidity and mortality in patients with craniopharyngioma after surgery
R. Crowley (2010)
10.3171/JNS.1980.52.5.0661
Transsphenoidal microsurgery in the management of craniopharyngioma.
E. Laws (1980)
10.1227/01.NEU.0000297074.13423.F5
ENDOSCOPIC RECONSTRUCTION OF THE CRANIAL BASE USING A PEDICLED NASOSEPTAL FLAP
A. Kassam (2008)
10.1002/path.1562
Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma
K. Kato (2004)
10.3171/2011.11.JNS111162
The "suprasellar notch," or the tuberculum sellae as seen from below: definition, features, and clinical implications from an endoscopic endonasal perspective.
M. de Notaris (2012)
10.1515/jpem-2014-0337
Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity
H. V. van Santen (2015)
10.1172/JCI15736
Selective parasympathetic innervation of subcutaneous and intra-abdominal fat--functional implications.
F. Kreier (2002)
10.1007/s00381-005-1246-x
Endocrine manifestations of craniopharyngioma
I. Halac (2005)
10.1530/EJE-14-0934
Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas.
D. C. Gomes (2015)
10.1002/oby.21067
Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity
C. Roth (2015)
10.1016/0167-8140(93)90019-5
Craniopharyngioma--a long-term results following limited surgery and radiotherapy.
B. Rajan (1993)
10.1186/2045-3701-2-14
Wnt signaling in development and disease
Y. Yang (2012)
10.1055/s-0038-1623519
Resection of a Retrochiasmatic Craniopharyngioma by Combined Modified Orbital Craniotomy and Transnasal Endoscopic Techniques
N. Patel (2018)
10.3171/2016.9.FOCUS16284
Microscopic versus endoscopic approaches for craniopharyngiomas: choosing the optimal surgical corridor for maximizing extent of resection and complication avoidance using a personalized, tailored approach.
J. Liu (2016)
10.1212/WNL.48.1.160
Amnesia Following Damage to the Mammillary Bodies
Y. Tanaka (1997)
10.1016/S1042-3680(18)30198-0
Radiosurgery for pituitary tumors and craniopharyngiomas.
E. Laws (1999)
10.1016/j.brainresbull.2012.10.003
The neurobiology of abnormal manifestations of aggression—A review of hypothalamic mechanisms in cats, rodents, and humans
J. Haller (2013)
10.1097/01.mlg.0000234933.37779.e4
A Novel Reconstructive Technique After Endoscopic Expanded Endonasal Approaches: Vascular Pedicle Nasoseptal Flap
G. Hadad (2006)
10.1002/lary.27600
Lack of Sphenoid Pneumatization Does Not Affect Endoscopic Endonasal Pediatric Skull Base Surgery Outcomes
E. C. Kuan (2019)
10.1016/j.ctrv.2018.11.004
Proton therapy for treatment of intracranial benign tumors in adults: A systematic review.
P. Lesueur (2019)
10.1530/EJE-15-0957
ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.
P. Brastianos (2016)
10.1016/j.metabol.2012.08.001
Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss.
C. Roth (2013)
10.1146/ANNUREV.CELLBIO.20.010403.113126
The Wnt signaling pathway in development and disease.
C. Y. Logan (2004)
10.1530/EJE-14-1123
Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study.
Christopher J. Child (2015)
10.3171/JNS.1999.90.2.0251
Surgical treatment of craniopharyngiomas: endocrinological results.
J. Honegger (1999)
10.1002/cncr.22703
Achievement of long‐term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy
S. Combs (2007)
10.1227/01.neu.0000326017.84315.1f
“GASKET‐SEAL” WATERTIGHT CLOSURE IN MINIMAL‐ACCESS ENDOSCOPIC CRANIAL BASE SURGERY
L. Leng (2008)
10.1007/s11060-017-2465-1
Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases
P. Malgulwar (2017)
10.3389/fendo.2012.00023
Bariatric Surgery in Hypothalamic Obesity
Nathan C Bingham (2012)
10.1212/WNL.41.5.726
Disruption of human circadian and cognitive regulation following a discrete hypothalamic lesion: A case study
R. Cohen (1991)
10.1016/j.clon.2018.01.012
Proton Therapy for Craniopharyngioma - An Early Report from a Single European Centre.
T. Ajithkumar (2018)
10.1007/s10143-018-0978-5
Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review
Josephine R Coury (2018)
10.1227/01.NEU.0000219897.98238.A3
The Endoscopic Extended Transsphenoidal Approach for Craniopharyngiomas
G. Frank (2006)
10.1016/S0090-3019(97)00507-7
Neuropsychological results of craniopharyngioma surgery in adults: a prospective study.
J. Honegger (1998)
10.1016/S0079-6123(08)64573-2
The human hypothalamus in relation to gender and sexual orientation.
D. Swaab (1992)
10.3928/01913913-20110208-03
Initial visual field as a predictor of recurrence and postoperative visual outcome in children with craniopharyngioma.
M. J. Lee (2012)
10.1002/1097-0142(19950615)75:12<2971::AID-CNCR2820751227>3.0.CO;2-6
Embryonal craniopharyngioma. Case report of the morphogenesis of a craniopharyngioma
H. Yamada (1995)
10.1167/iovs.07-1127
In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors.
H. Danesh-Meyer (2008)
10.1007/978-3-319-21533-4_9
Draining Techniques for Cystic Craniopharyngiomas
A. Delitala (1997)
10.1203/pdr.0b013e3180332cd6
Reduced Sympathetic Metabolites in Urine of Obese Patients With Craniopharyngioma
C. Roth (2007)
10.3171/2010.11.JNS10612
Technique and outcome of endoscopy-assisted microscopic extended transsphenoidal surgery for suprasellar craniopharyngiomas.
E. H. Kim (2011)
10.1159/000074498
Ascertainment and Treatment of Delayed Puberty
J. Pozo (2003)
Craniopharyngioma: radiologic and histologic findings and recurrence.
O. P. Eldevik (1996)
10.3109/02688697.2012.741732
Surprising outcome of ommaya reservoir in treating cystic craniopharyngioma: a retrospective study
A. H. Moussa (2013)
Cirrhotic outcome in patients with craniopharyngioma.
B. Altuntaş (2002)
10.1016/j.wneu.2011.07.011
Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas.
R. Komotar (2012)
10.1007/s00701-004-0295-3
Intraventricular craniopharyngiomas: topographical classification and surgical approach selection based on an extensive overview
J. M. Pascual (2004)
10.1530/JOE-15-0145
60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models.
J. P. Martinez-Barbera (2015)
10.1016/1043-2760(94)00090-Q
Embryology of the pituitary gland
P. M. Dubois (1995)
10.1111/j.1365-2265.2007.02784.x
The influence of the route of oestrogen administration on serum levels of cortisol‐binding globulin and total cortisol
A. Qureshi (2007)
[Long-term outcome of the adult onset craniopharyngiomas].
N. Baldé (2007)
10.1097/00006123-200111000-00005
Memory Deficits among Children with Craniopharyngiomas
S. Carpentieri (2001)
10.3892/ijmm.3.2.157
Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma.
T. Nishi (1999)
10.1016/0360-3016(84)90235-9
Surgery and radiation therapy in the management of craniopharyngiomas.
J. Hoogenhout (1984)
10.2174/138161213804581837
Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
A. Voronkov (2013)
The beta-catenin destruction complex
J L Stamos (2013)
10.1016/j.wneu.2017.09.164
Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis.
Nawaf M. Alotaibi (2018)
10.3171/2017.4.JNS162143
Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
Yun Sik Dho (2018)
10.1055/b-0034-79208
Complications in Endoscopic Skull Base Surgery
M. Bernal-Sprekelsen (2013)
10.1016/j.wneu.2017.08.058
Outcomes After Endoscopic Endonasal Resection of Craniopharyngiomas in the Pediatric Population.
V. Patel (2017)
10.23736/S0391-1977.18.02834-1
Growth hormone deficiency and pregnancy: any role for substitution?
G. Vila (2018)
10.3171/JNS/2008/108/4/0715
Expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum.
A. Kassam (2008)
10.1007/s00381-004-0943-1
Purely neuroendoscopic transventricular management of cystic craniopharyngiomas
A. Delitala (2004)
10.3171/FOC.2003.14.5.14
Long-term results of gamma knife surgery for craniopharyngioma.
T. Kobayashi (2003)
10.1259/0007-1285-49-579-206
Craniopharyngioma: based on 160 cases.
M. Banna (1976)
10.1007/s00401-005-1004-x
Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region
R. Buslei (2005)
10.1007/s11060-011-0693-3
Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma
H. Iwata (2011)
10.2176/NMC.37.141
Surgical management of craniopharyngiomas: a review.
M. Samii (1997)
10.3171/JNS.1996.85.1.0073
Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?
C. D. de Vile (1996)
10.1210/JCEM.83.11.5240
Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence.
B. Bülow (1998)
10.3171/JNS.1985.62.4.0496
Treatment of craniopharyngiomas in children: 1972-1981.
E. G. Fischer (1985)
10.3171/JNS.1985.62.2.0174
Radical excision of craniopharyngioma. Results in 20 patients.
L. Symon (1985)
10.1097/SCS.0000000000003920
Effect of Preserving the Pituitary Stalk During Resection of Craniopharyngioma in Children on the Diabetes Insipidus and Relapse Rates and Long-Term Outcomes
Jing Cheng (2017)
10.3171/2012.6.FOCUS12125
Norman Dott, Gerard Guiot, and Jules Hardy: key players in the resurrection and preservation of transsphenoidal surgery.
S. Patel (2012)
10.3171/2016.9.FOCUS16211
Aggressive surgery based on an anatomical subclassification of craniopharyngiomas.
H. Morisako (2016)
10.1007/s00701-011-1149-4
Infundibulo-tuberal or not strictly intraventricular craniopharyngioma: evidence for a major topographical category
José M Pascual (2011)
10.3171/PED.2007.106.1.3
Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.
S. Puget (2007)
10.3171/FOC/2008/24/5/E4
Radiation therapy and CyberKnife radiosurgery in the management of craniopharyngiomas.
Marco B Lee (2008)
10.1007/s00701-015-2519-0
Prognostic factors of craniopharyngioma with special reference to autocrine/paracrine signaling: underestimated implication of growth hormone receptor
Y. Ogawa (2015)
10.1210/jc.2011-0174
Consequences of craniopharyngioma surgery in children.
H. Müller (2011)
Neuroimaging of pediatric craniopharyngiomas: a pictorial essay.
A. Rossi (2006)
10.1007/s10552-005-9012-7
Melatonin Treatment in Obese Patients with Childhood Craniopharyngioma and Increased Daytime Sleepiness
H. Müller (2005)
10.1007/s007010200058
Craniopharyngioma in a Mother and Daughter
A. L. Green (2002)
10.1007/978-3-7091-8975-7_23
Further experiences in the treatment of cystic craniopharyngeomas with yttrium 90 silicate colloid.
J. Julow (1988)
10.1007/s00381-018-3925-4
Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature
R. Borrill (2018)
10.1016/0360-3016(93)90227-M
20-year experience in childhood craniopharyngioma.
S. Hetelekidis (1993)
10.1007/s00381-012-1926-2
A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma
A. Clark (2012)
10.1007/s00381-005-1189-2
Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas—a study in single institute
Sung Ho Moon (2005)
10.1146/ANNUREV.PSYCH.53.100901.135114
Episodic memory: from mind to brain.
E. Tulving (2002)
10.1007/s11102-019-00983-7
Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007
S. Boekhoff (2019)
10.1155/2011/417949
Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy
J. Hamilton (2011)
10.1530/EJE-18-0505
Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).
S. Boekhoff (2018)
10.1016/j.autneu.2017.08.006
Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation
M. Foschi (2017)
10.1227/01.NEU.0000255528.68963.EF
LONG‐TERM RESULTS AND LATE COMPLICATIONS AFTER INTRACAVITARY YTTRIUM‐90 COLLOID IRRADIATION OF RECURRENT CYSTIC CRANIOPHARYNGIOMAS
Jenö Julow (2007)
10.3171/2013.V1.FOCUS12330
Surgical management of craniopharyngioma with third ventricle involvement.
D. de Lara (2013)
Pediatric classification and treatment according to the degree of hypothalamic involvement
S Puget (2007)
10.3109/02699052.2011.648709
Quality‐of‐life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy
C. Laffond (2012)
10.1210/jc.2007-2672
Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity.
M. G. Shaikh (2008)
10.5414/CPP42212
Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome.
J. Wysocki (2004)
10.1227/01.NEU.0000335786.10968.2F
MANAGEMENT OF CYSTIC CRANIOPHARYNGIOMAS WITH STEREOTACTIC ENDOCAVITARY IRRADIATION USING COLLOIDAL 186: A RETROSPECTIVE STUDY OF 48 CONSECUTIVE PATIENTS
S. Derrey (2008)
10.1007/s00415-007-2004-7
Neuropsychological assessment
W. Sturm (2007)
10.3748/wjg.v19.i31.5051
Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.
E. Pavlidis (2013)
10.1097/00001665-200011050-00002
Endoscopic Transglabellar Approach to the Anterior Fossa and Paranasal Sinuses
R. Jarrahy (2000)
10.1016/j.ijrobp.2012.03.066
Learning and memory following conformal radiation therapy for pediatric craniopharyngioma and low-grade glioma.
Marcos Di Pinto (2012)
10.1007/BF00666218
The pars tuberalis of the human pituitary
S. Asa (2004)
10.3171/2010.2.FOCUS09304
Craniopharyngioma Clinical Status Scale: a standardized metric of preoperative function and posttreatment outcome.
R. Elliott (2010)
Aspects radiologiques des craniopharyngiomes
C. Raybaud (1991)
10.1186/s40478-016-0287-6
Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles
A. Hoelsken (2016)
10.1093/neuonc/nos142
Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.
B. Zacharia (2012)
10.1016/B978-0-444-52901-5.00032-0
Neurobehavioral disorders.
N. Zasler (2013)
10.1186/s13046-017-0562-9
Can recurrences be predicted in craniopharyngiomas? β-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases
E. Guadagno (2017)
10.1371/journal.pone.0044304
Development and Validation of a New Questionnaire Assessing Quality of Life in Adults with Hypopituitarism: Adult Hypopituitarism Questionnaire (AHQ)
H. Ishii (2012)
10.1007/s00381-005-1201-x
Radical resection of craniopharyngioma
G. Zuccaro (2005)
10.1111/nan.12201
BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts
L. Schweizer (2015)
10.1016/j.wneu.2018.06.121
Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review.
Weimin Ni (2018)
10.1111/dmcn.13444
Psychological well‐being and independent living of young adults with childhood‐onset craniopharyngioma
Rodica Mia Memmesheimer (2017)
10.1210/JCEM.81.7.8675604
Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.
C. D. de Vile (1996)
10.1007/s12020-015-0683-x
Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas
P. Mortini (2015)
10.23736/S0390-5616.18.04331-X
Limits of endoscopic endonasal surgery for III ventricle craniopharyngiomas.
Douglas A. Hardesty (2018)
10.1016/j.arcmed.2012.06.009
Treatment of craniopharyngioma in adults: systematic analysis of a 25-year experience.
Raúl López-Serna (2012)
Fully endoscopic endonasal resection of parasellar craniopharyngiomas: an early experience and review of literature
A. Kassam (2004)
10.1210/JC.2016-2118
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline.
M. Fleseriu (2016)
10.1016/0165-6147(86)90270-1
Growth without growth hormone.
M. Phillip (2002)
10.1101/cshperspect.a008052
Wnt signaling in cancer.
P. Polakis (2012)
10.1159/000120869
The role of radiation therapy in the treatment of craniopharyngioma.
W. Wara (1994)
10.1210/en.2016-1967
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors
W. Bi (2017)
10.1530/EJE-18-1021
MANAGEMENT OF ENDOCRINE DISEASE: Childhood-onset Craniopharyngioma: state of the art of care in 2018.
H. Müller (2019)
10.3171/JNS.2005.103.2.0224
Surgical management of the recurrence and regrowth of craniopharyngiomas.
Y. Minamida (2005)
10.1055/S-2002-36197
Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures.
P. Cappabianca (2002)
10.1016/j.clon.2013.07.005
Radiotherapy in craniopharyngiomas.
A. Iannalfi (2013)
10.1227/NEU.0b013e31826d5c31
Intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review).
W. Liu (2012)
10.3171/2009.2.JNS081026
Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas.
L. Cavallo (2009)
10.1007/s00381-016-3131-1
Extensive miRNA expression analysis in craniopharyngiomas
J. Samis (2016)
10.3171/2010.1.FOCUS09315
Intracystic treatments for craniopharyngioma.
P. Steinbok (2010)
10.3171/FOC.2005.19.1.5
Expanded endonasal approach: the rostrocaudal axis. Part II. Posterior clinoids to the foramen magnum.
A. Kassam (2005)
10.1007/s00381-005-1226-1
Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma
S. Cavalheiro (2005)
10.3171/2016.9.JNS16702
Norman M. Dott, master of hypothalamic craniopharyngioma surgery: the decisive mentoring of Harvey Cushing and Percival Bailey at Peter Bent Brigham Hospital.
R. Prieto (2017)
10.3171/2018.5.JNS18154
Harvey Cushing's craniopharyngioma treatment: Part 2. Surgical strategies and results of his pioneering series.
R. Prieto (2018)
10.1016/bs.pbr.2015.03.006
The mammillary bodies and memory: more than a hippocampal relay.
S. Vann (2015)
10.1016/B978-0-12-416706-3.00018-0
Surgical Approaches: Complications of Surgical Management
R. Louis (2015)
10.1038/oby.2010.80
Appetite‐Regulating Hormone Changes in Patients With Craniopharyngioma
C. Roth (2011)
10.2174/97816810853261170401
Craniopharyngiomas - Classification and Surgical Treatment
Song-tao Qi (2017)
10.18632/oncotarget.23695
Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
C. Gao (2018)
10.3171/2015.4.PEDS159
Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for craniopharyngioma.
Chiaho Hua (2015)
10.23736/S0390-5616.18.04376-X
The limits of transsellar/transtuberculum surgery for craniopharyngioma.
M. Koutourousiou (2018)
10.3171/jns.2001.95.5.0917
Extended transsphenoidal approach.
G. Frank (2001)
10.1016/S0360-3016(99)00030-9
The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature.
J. Habrand (1999)
10.1159/000163383
Long-term results of gamma knife radiosurgery for 100 consecutive cases of craniopharyngioma and a treatment strategy.
T. Kobayashi (2009)
10.1007/s00381-012-1787-8
Management of craniopharyngioma: the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system
C. Mallucci (2012)
10.3171/jns.1998.89.4.0547
The descriptive epidemiology of craniopharyngioma.
G. Bunin (1997)
10.1515/jpem-2015-0445
Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma
N. Cook (2016)
10.1227/01.NEU.0000178353.42777.2C
Ten-year Experience with the Supraorbital Subfrontal Approach through an Eyebrow Skin Incision
R. Reisch (2005)
10.1227/01.NEU.0000120421.11171.61
Tumor-Third Ventricular Relationships in Supradiaphragmatic Craniopharyngiomas: Correlation of Morphological, Magnetic Resonance Imaging, and Operative Findings
J. Štěňo (2004)
10.1159/000120866
Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma--a 20-year experience.
R. Scott (1994)
10.1227/01.neu.0000303220.55393.73
EXTENDED ENDOSCOPIC TRANSSPHENOIDAL APPROACH FOR EXTRASELLAR CRANIOPHARYNGIOMAS
E. de Divitiis (2007)
10.1007/s007010050123
Management of Recurrent Craniopharyngioma
M. Caldarelli (1998)
10.3171/JNS.2000.93.SUPPLEMENT
Gamma knife radiosurgery for craniopharyngiomas.
W. Chung (2000)
10.1111/cen.12523
Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma
J. Roemmler-Zehrer (2015)
10.1530/EJE-09-0449
Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
H. Holmer (2009)
10.1530/EJE-17-0044
Very long-term sequelae of craniopharyngioma.
M. Wijnen (2017)
10.3171/2018.10.JNS182154
Lessons learned in the evolution of endoscopic skull base surgery.
T. Schwartz (2019)
10.1007/s11102-012-0429-1
Radiotherapy for craniopharyngioma
A. Aggarwal (2012)
10.1016/J.RADONC.2006.11.005
Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.
G. Minniti (2007)
10.3171/JNS.1990.73.1.0003
Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients.
M. Yașargil (1990)
10.3171/JNS.1992.76.1.0047
Aggressive surgical management of craniopharyngiomas in children.
H. Hoffman (1992)
Manual for the child behavior checklist/4-18 and 1991 profile
T. M. Achenbach (1991)
10.1016/j.neubiorev.2013.07.001
A revised limbic system model for memory, emotion and behaviour
M. Catani (2013)
10.1016/0090-3019(92)90229-G
Transsphenoidal microsurgery for craniopharyngioma.
J. Honegger (1992)
10.1016/j.pediatrneurol.2007.11.007
Cardiac risk after craniopharyngioma therapy.
S. Mong (2008)
10.1136/ADC.2007.121087
Not just small adults: the metaphors of paediatrics
J. Gillis (2007)
Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas. Neurosurgery
J Julow (2007)
Rehabilitation jugendlicher Kraniopharyngeom-Patienten. Rehabilitation
T Flick (1986)
Response to Craniopharyngiomas and the hypothalamus
J M Pascual (2013)
WHO classification of tumors of the central nervous system
R Buslei (2016)
10.1016/j.wneu.2014.10.002
Optic chiasm distortions caused by craniopharyngiomas: clinical and magnetic resonance imaging correlation and influence on visual outcome.
R. Prieto (2015)
10.1007/s00381-010-1296-6
Toothy craniopharyngioma: a literature review and case report of craniopharyngioma with extensive odontogenic differentiation and tooth formation
Craig Muller (2010)
10.1080/13803390802064599
Neuropsychological functioning following craniopharyngioma removal
H. Bawden (2009)
10.1227/01.neu.0000317374.30443.23
ENDOSCOPIC ENDONASAL PITUITARY TRANSPOSITION FOR A TRANSDORSUM SELLAE APPROACH TO THE INTERPEDUNCULAR CISTERN
A. Kassam (2008)
10.3171/JNS/2008/108/5/1043
The evolution of the endonasal approach for craniopharyngiomas.
P. Gardner (2008)
10.1007/978-3-7091-6084-8_11
Extended endoscopic endonasal transsphenoidal approaches to the suprasellar region, planum sphenoidale & clivus
P. Cappabianca (2003)
10.1038/sj.ijo.0801045
The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females
K. Walsh (1999)
10.1159/000120855
Pathology of craniopharyngiomas: clinical import of pathological findings.
D. Miller (1994)
10.1530/EJE-11-0229
Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma.
H. Holmer (2011)
10.3171/2010.1.FOCUS09303
Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity.
J. V. Van Gompel (2010)
10.1007/s11060-013-1128-0
Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma
Seung Wan Park (2013)
10.3389/fendo.2011.00078
Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity
Clinton T. Elfers (2011)
10.1055/s-0031-1284420
Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB).
H. Müller (2011)
10.1055/S-2000-8813
Transsphenoidal supradiaphragmatic intradural approach: technical note.
J. Kim (2000)
10.1080/03014460310001636570
Multiple prepubertal growth spurts in children of the Fels Longitudinal Study: comparison with results from the Edinburgh Growth Study
R. Bock (2004)
10.1055/s-0038-1624585
Transcallosal, Transchoroidal Resection of a Recurrent Craniopharyngioma
W. Jean (2018)
10.1055/S-2008-1046584
Entwicklung einer kompletten Lebercirrhose bei Hyperphagie-bedingter Fettleber
D. Basenau (1994)
10.3171/JNS.1975.42.1.0086
Late results of radical excision of craniopharyngiomas in children.
E. L. Katz (1975)
10.1227/01.NEU.0000255354.64077.66
GRADED REPAIR OF CRANIAL BASE DEFECTS AND CEREBROSPINAL FLUID LEAKS IN TRANSSPHENOIDAL SURGERY
F. Esposito (2007)
10.1007/s00381-010-1330-8
Craniopharyngiomas in children: how radical should the surgeon be?
J. Šteňo (2010)
10.1159/000120861
Surgical management of craniopharyngioma.
H. Hoffman (1994)
Frizzled and LRP5/6 receptors for Wnt/beta-catenin signaling
B T Macdonald (2012)
The transnasal transsphenoidal approach. In: Apuzzo MLJ, editor. Surgery of the third ventricle
MH Weiss (1987)
Long term results of stereotactic endocavitary beta irradiation of craniopharyngioma cysts.
C. Munari (1989)
10.1097/00006123-200010000-00014
Craniopharyngiomas of the Third Ventricle: Trans-Lamina Terminalis Approach
G. Maira (2000)
10.1016/S0889-8529(05)70345-5
The growth without growth hormone syndrome.
M. Geffner (1996)
10.1309/AJCP37TLZLTUAOJL
VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations.
Daniel A. Mordes (2014)
10.14310/HORM.2002.1208
Craniopharyngiomas. Historical aspects of their management
E. Roderick (2008)
10.1016/j.ijrobp.2010.11.027
Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
Nicholas S. Boehling (2012)
10.1080/14737175.2018.1528874
Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up
A. Bogusz (2018)
10.1210/JC.2002-030003
Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial.
R. Lustig (2003)
10.1080/0268869031000108864
Stereotactic radiosurgery XVII: recurrent intrasellar craniopharyngioma
A. S. Jackson (2003)
10.2169/NAIKA.94.479
[Diagnosis and treatment of hypopituitarism].
K. Hashimoto (2005)
10.1097/COC.0000000000000378
The Role of Definitive Radiotherapy in Craniopharyngioma: A SEER Analysis
C. Zhang (2018)
10.3171/JNS.2008.109.12.1180
Craniopharyngioma classification.
José M Pascual (2008)
10.1007/s11102-015-0660-7
Infundibulo-tuberal syndrome: the origins of clinical neuroendocrinology in France
I. Castro-Dufourny (2015)
10.3171/2010.2.FOCUS09318
Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships.
G. Zada (2010)
10.1016/j.ando.2017.10.007
Group 4: Replacement therapy for adrenal insufficiency.
F. Castinetti (2017)
10.1007/s11102-012-0418-4
Pathology and pathogenesis of craniopharyngiomas
Sarah J. Larkin (2012)
10.1055/S-2003-45499
Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma.
H. Müller (2003)
10.3389/fendo.2011.00049
Hypothalamic Obesity in Patients with Craniopharyngioma: Profound Changes of Several Weight Regulatory Circuits
C. Roth (2011)
10.1111/j.1469-8749.2010.03887.x
Functional analysis and treatment of aggressive behavior following resection of a craniopharyngioma
J. Hammond (2011)
10.1530/EJE-09-0319
GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies.
H. Filipsson (2009)
10.1016/j.oooo.2018.11.004
Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation.
C. Gomes (2019)
10.3340/jkns.2015.58.5.432
Is the Complete Resection of Craniopharyngiomas in Adults Feasible Considering Both the Oncologic and Functional Outcomes?
E. Lee (2015)
10.1242/dev.150490
MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma
S. Haston (2017)
The transnasal transsphenoidal approach
M H Weiss (1987)
10.1007/s00401-013-1118-5
VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
J. Sperveslage (2013)
10.3171/2018.4.JNS172330
A modern series of subdiaphragmatic craniopharyngiomas.
Ali O. Jamshidi (2018)
10.3171/JNS/2008/109/7/0006
Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series.
P. Gardner (2008)
10.1371/journal.pone.0004815
A GRFa2/Prop1/Stem (GPS) Cell Niche in the Pituitary
Montse Garcia-Lavandeira (2009)
10.1055/s-0038-1623522
Endoscopic Endonasal Approach for a Suprasellar Craniopharyngioma
G. Zenonos (2018)
10.1093/neuonc/nov044
Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes.
A. Sterkenburg (2015)
10.1016/j.wneu.2014.07.023
The role of the endoscopic endonasal route in the management of craniopharyngiomas.
L. Cavallo (2014)
10.1001/ARCHPEDI.156.9.887
The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma.
P. Mason (2002)
10.1530/EC-19-0074
Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma
A. Bogusz (2019)
10.1111/ijpo.12527
Eating behaviour and oxytocin in patients with childhood‐onset craniopharyngioma and different grades of hypothalamic involvement
A. M. Daubenbüchel (2019)
10.1210/jc.2013-2000
Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma.
S. Fjalldal (2013)
10.1530/EJE.1.01877
The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
P. Kendall-Taylor (2005)
10.1007/s11060-014-1600-5
The ophthalmic natural history of paediatric craniopharyngioma: a long-term review
E. Drimtzias (2014)
10.3171/JNS.1999.90.2.0237
Surgical treatment of craniopharyngiomas: experience with 168 patients.
R. Fahlbusch (1999)
10.1212/WNL.22.2.117
Korsakoff's syndrome associated with surgical lesions involving the mammillary bodies
E. A. Kahn (1972)
10.1016/j.wneu.2012.07.033
Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence.
R. Prieto (2013)
10.1007/s10143-009-0186-4
The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma
G. Minniti (2009)
10.1016/S0022-3476(80)80254-X
Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients.
M. J. Thomsett (1980)
10.1016/j.clineuro.2013.04.010
Trans-lamina terminalis approach for third ventricle and suprasellar tumours
P. Silva (2013)
10.1080/03014469000000952
The cyclical nature of prepubertal growth.
G. E. Butler (1990)
10.3171/2010.11.JNS10670
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series.
P. Mortini (2011)
10.1007/s11060-012-0806-7
The superiority of conservative resection and adjuvant radiation for craniopharyngiomas
Adam Schoenfeld (2012)
10.1007/s12022-014-9341-8
The Wnt Signalling Cascade and the Adherens Junction Complex in Craniopharyngioma Tumorigenesis
V. Preda (2014)
10.1530/EJE-09-0079
Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma.
B. Schultes (2009)
10.1007/s003810050207
Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma
D. Riva (1998)
10.1530/EJE.0.1380089
Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite.
C. Roth (1998)
10.1007/s00381-004-1124-y
Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma
H. Müller (2004)
10.3389/fendo.2011.00070
Diagnostics, Treatment, and Follow-Up in Craniopharyngioma
H. Müller (2011)
10.1056/NEJMoa1003114
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.
W. P. James (2010)
10.1007/s10014-005-0191-4
Histological findings at the boundary of craniopharyngiomas
T. Kawamata (2005)
10.1007/s00701-009-0580-2
Natura Abhorret a Vacuo—use of fibrin glue as a filler and sealant in neurosurgical “dead spaces”. Technical note
P. Cappabianca (2009)
10.1055/S-2001-16855
Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.
H. Müller (2001)
10.1111/aos.13483
Predictors of visual outcome in patients operated for craniopharyngioma – a Danish national study
Mads Forslund Jacobsen (2018)
Intracranial neoplasms in children: a comparison of North America, Europe, Africa, and Asia.
G. Dohrmann (1976)
10.1007/s11060-018-2936-z
Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma
A. Mehren (2018)
10.3109/01658107.2015.1039549
Visual Outcomes, Visual Fields, and Optical Coherence Tomography in Paediatric Craniopharyngioma
S. Mediero (2015)
10.3171/2016.2.FOCUS1592
Harvey Cushing and pituitary Case Number 3 (Mary D.): the origin of this most baffling problem in neurosurgery.
José M Pascual (2016)
10.1097/00006842-194007000-00005
Personality and Emotional Disorders Associated with Hypothalamic Lesions
B. J. Alpers (1940)
10.1159/000103306
Craniopharyngiomas in Children
Kazumi Ohmori (2007)
Does chemotherapy have a role in the management of craniopharyngioma?
D. Hargrave (2006)
10.1111/j.1365-2559.2003.01751.x
Cathepsin B, D and K expression in adamantinomatous craniopharyngiomas relates to their levels of differentiation as determined by the patterns of retinoic acid receptor expression
A. Lubansu (2003)
10.1002/pbc.26911
The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well‐defined cohort
Laura van Iersel (2018)
10.1210/jc.2011-2187
Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors.
M. García-Lavandeira (2012)
10.3171/2016.8.FOCUS16307
Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice.
J. Apps (2016)
10.1515/JPEM.2006.19.2.121
Weight Gain in Craniopharyngioma - A Model for Hypothalamic Obesity
Arik Ahmet (2006)
10.1016/0167-8140(93)90039-B
Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation.
W. Regine (1993)
10.1001/ARCHNEUR.1983.04050080060011
Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function.
R. Haugh (1983)
10.1111/j.1651-2227.2010.01867.x
Risk factors for obesity in childhood survivors of suprasellar brain tumours: a retrospective study
N. Lek (2010)
10.1111/J.1365-2214.1981.TB00848.X
Intellectual and psychosocial functions of children, adolescents and young adults before and after operation for craniopharyngioma.
A. Galatzer (1981)
10.1016/j.jocn.2004.03.008
Operative technique: The anterior transcallosal transseptal interforniceal approach to the third ventricle and resection of hypothalamic hamartomas
J. Rosenfeld (2004)
10.1007/s00381-010-1301-0
Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma
Agnieszka Ondruch (2010)
10.1001/ARCHPEDI.1986.02140210108037
Frontal lobe lesions and cognitive function in craniopharyngioma survivors.
M. Stelling (1986)
10.1016/j.neubiorev.2014.07.025
How do mammillary body inputs contribute to anterior thalamic function?
C. Dillingham (2015)
10.1007/s003810050108
Long-term results of treatment for craniopharyngioma in children
G. Tomei (1997)
10.1007/s007010050167
Transsphenoidal-Transtuberculum Sellae Approach for Supradiaphragmatic Tumours: Technical Note
T. Kato (1998)
10.1227/01.NEU.0000327857.22221.53
ENDONASAL VERSUS SUPRAORBITAL KEYHOLE REMOVAL OF CRANIOPHARYNGIOMAS AND TUBERCULUM SELLAE MENINGIOMAS
N. Fatemi (2009)
10.1136/bjo.85.3.322
Vision impairment predicts 5 year mortality
C. McCarty (2001)
10.1227/NEU.0b013e31821a872d
Surgical Management of Craniopharyngiomas in Children: Meta-analysis and Comparison of Transcranial and Transsphenoidal Approaches
R. Elliott (2011)
10.3171/2018.5.JNS18198
Endonasal endoscopic transsphenoidal resection of intrinsic third ventricular craniopharyngioma: surgical results.
J. Forbes (2018)
10.1007/s00401-014-1270-6
BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma
Sarah J. Larkin (2014)
10.3171/2018.6.JNS18901
Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas.
E. G. Ordóñez-Rubiano (2018)
10.3390/cancers10110401
Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location
S. Adeberg (2018)
10.1515/jpem-2014-0415
Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma
A. Hoffmann (2015)
10.1210/JCEM.87.8.8751
Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients.
H. Müller (2002)
10.1016/j.ijrobp.2014.05.051
Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity.
A. Bishop (2014)
10.1007/s12020-016-1084-5
Oxytocin in survivors of childhood-onset craniopharyngioma
A. M. Daubenbüchel (2016)
10.3171/PED.2006.105.4.306
Angiogenesis and cell proliferation in human craniopharyngioma xenografts in nude mice.
J. Xu (2006)
10.1530/EJE-14-0824
Extensive expertise in endocrinology. Adrenal crisis.
B. Allolio (2015)
10.1155/2010/519607
Increased Daytime Sleepiness in Patients with Childhood Craniopharyngioma and Hypothalamic Tumor Involvement: Review of the Literature and Perspectives
H. Müller (2010)
10.3171/2013.1.JNS111722
Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis.
José M Pascual (2013)
10.1111/dom.13021
Effects of MetAP2 inhibition on hyperphagia and body weight in Prader–Willi syndrome: A randomized, double‐blind, placebo‐controlled trial
S. McCandless (2017)
10.1007/s00381-005-1209-2
Craniopharyngioma: the pendulum of surgical management
C. Sainte-Rose (2005)
10.1055/a-0593-5956
Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas.
C. Jucá (2018)
10.1002/1097-0142(197604)37:4<1944::AID-CNCR2820370446>3.0.CO;2
Craniopharyngiomas: a clinical and pathological review.
C. Petito (1976)
10.1200/JCO.2005.03.8547
Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy.
E. Kiehna (2006)
10.1016/j.wneu.2018.09.053
Craniopharyngiomas Primarily Involving the Hypothalamus: A Model of Neurosurgical Lesions to Elucidate the Neurobiological Basis of Psychiatric Disorders.
José M Pascual (2018)
Historical aspects of their management
E Roderick (2008)
10.1007/s00428-009-0873-0
A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas
S. Burghaus (2009)
10.1007/s11060-018-2776-x
The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study
M. Chen (2018)
10.1016/S0079-6123(08)60413-6
SCN output drives the autonomic nervous system: with special reference to the autonomic function related to the regulation of glucose metabolism.
K. Nagai (1996)
10.1016/0360-3016(92)90705-M
Pediatric craniopharyngiomas: long term results of combined treatment with surgery and radiation.
W. Regine (1992)
10.3171/JNS-07/10/0713
Skull base reconstruction in the extended endoscopic transsphenoidal approach for suprasellar lesions.
L. Cavallo (2007)
10.1002/14651858.CD003641.pub4
Surgery for weight loss in adults.
J. Colquitt (2014)
10.1007/s10143-012-0439-5
Hypothalamus-referenced classification for craniopharyngiomas: evidence provided by the endoscopic endonasal approach
José M Pascual (2012)
10.1227/NEU.0b013e318262146b
Longitudinal analysis of visual outcomes after surgical treatment of adult craniopharyngiomas.
Younghoon Kim (2012)
10.1007/s003810050272
Outcomes and failure patterns in childhood craniopharyngiomas
P. Fisher (1998)
10.1002/J.1550-8528.1998.TB00308.X
Sibutramine reduces food intake in non-dieting women with obesity.
B. Rolls (1998)
10.1210/JC.2003-030552
Defect in epinephrine production in children with craniopharyngioma: functional or organic origin?
R. Coutant (2003)
10.1097/JNN.0b013e3181f8a59d
Health Status in Long-Term Survivors of Pediatric Craniopharyngiomas
D. Crom (2010)
10.1093/neuros/nyx570
Adult Craniopharyngioma: Case Series, Systematic Review, and Meta-Analysis
Charlotte Dandurand (2018)
10.1097/01.pas.0000213328.64121.12
Nuclear β-Catenin Accumulation as Reliable Marker for the Differentiation Between Cystic Craniopharyngiomas and Rathke Cleft Cysts: A Clinico-Pathologic Approach
B. Hofmann (2006)
10.1007/BF01772817
Management of primary or recurring grossly cystic craniopharyngiomas by means of draining systems
R. Spaziante (2005)
10.1097/00007611-198412000-00011
Craniopharyngioma Arising in the Pharyngeal Hypophysis
R. Lewin (1984)
10.1210/JC.2003-031751
Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.
H. Müller (2004)
10.3171/JNS.2002.96.2.0235
Pterional surgery of meningiomas of the tuberculum sellae and planum sphenoidale: surgical results with special consideration of ophthalmological and endocrinological outcomes.
R. Fahlbusch (2002)
10.1002/MPO.10247
Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.
J. Kalapurakal (2003)
10.1046/j.1365-2265.1997.2591079.x
Hypothalamic adipsic syndrome: diagnosis and management
S. Ball (1997)
10.1073/pnas.1101553108
Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans
C. Gaston-Massuet (2011)
10.1210/jc.2014-1680
Diencephalic syndrome in childhood craniopharyngioma--results of German multicenter studies on 485 long-term survivors of childhood craniopharyngioma.
A. Hoffmann (2014)
10.3171/JNS.1986.65.1.0022
Surgical management of craniopharyngiomas. A review of 74 cases.
D. Baskin (1986)
10.1093/neuonc/nox056
Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN
J. Kilday (2017)
10.1016/j.radonc.2015.01.016
Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice.
S. Scoccianti (2015)
10.1210/jc.2010-0993
Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma.
H. Holmer (2010)
10.1227/01.NEU.0000249211.89096.25
EXTENDED ENDOSCOPIC ENDONASAL TRANSSPHENOIDAL APPROACH FOR THE REMOVALOF SUPRASELLAR TUMORS: PART 2
E. de Divitiis (2007)
10.1530/EJE-14-1029
Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke's pouch: impact on long-term prognosis.
A. M. Daubenbüchel (2015)
10.1055/s-0034-1368785
Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007.
A. Hoffmann (2014)
10.1007/s12020-017-1257-x
First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma
A. Hoffmann (2017)
10.3233/CBM-140397
High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children.
J. Gong (2014)
10.1227/01.neu.0000289708.49684.47
EXTENDED ENDOSCOPIC ENDONASAL TRANSSPHENOIDAL APPROACH TO THE SUPRASELLAR AREA: ANATOMIC CONSIDERATIONS—PART 1
L. Cavallo (2007)
10.3171/2014.3.JNS131521
The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients.
L. Cavallo (2014)
10.1227/01.NEU.0000114262.30035.AF
Management of Cystic Craniopharyngiomas with Phosphorus-32 Intracavitary Irradiation
T. Hasegawa (2004)
10.1055/s-0038-1625941
Microsurgical Resection of Suprasellar Craniopharyngioma—Technical Purview
A. Nanda (2018)
10.1016/S0360-3016(02)03029-8
Fractionated stereotactic radiotherapy for craniopharyngiomas.
D. Schulz-Ertner (2002)
10.1111/neup.12408
High‐resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas
K. Yoshimoto (2018)
10.1093/neuonc/3.3.159
Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy.
S. M. Chiou (2001)
10.1007/978-3-7091-8813-2_16
Microsurgical topography of craniopharyngiomas.
J. Štěňo (1985)
10.1007/978-3-211-72283-1_4
Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery.
P. Cappabianca (2008)
10.1007/s11060-010-0145-5
Late mortality in pediatric patients with craniopharyngioma
J. Visser (2010)
10.3171/2016.4.PEDS16112
Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
T. Smith (2016)
10.1007/s00701-010-0938-5
Intraventricular craniopharyngioma: morphological analysis and outcome evaluation of 17 cases
J. Pan (2010)
10.3171/JNS.1981.55.3.0371
Craniopharyngiomas: a critical approach to treatment.
J. Cabezudo (1981)
10.1080/0284186X.2016.1270466
Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort
A. Astradsson (2017)
10.3389/fendo.2011.00096
Surgical Strategies in Childhood Craniopharyngioma
J. Flitsch (2011)
10.1186/s12902-016-0117-7
How should we interrogate the hypothalamic-pituitary-adrenal axis in patients with suspected hypopituitarism?
A. Garrahy (2016)
10.2176/nmc.oa.2018-0028
Endoscopic Endonasal Surgery for Subdiaphragmatic Type Craniopharyngiomas
H. Nishioka (2018)
10.1093/jnci/djv310
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
P. Brastianos (2016)
10.3171/2016.1.FocusVid.15416
Subfrontal trans-lamina terminalis approach to a third ventricular craniopharyngioma.
Omar Choudhri (2016)
10.1097/00006123-200212000-00005
Tuberculum sellae meningioma: a report on management on the basis of a surgical experience with 70 patients.
A. Goel (2002)
Gasket-seal” watertight closure in minimalaccess endoscopic cranial base surgery. Neurosurgery
LZ Leng (2008)
Kleinschmidt-DeMasters BK. Neurobehavioral outcome in pediatric craniopharyngioma
C A Anderson (1997)
Craniopharyngioma adherence to the hypothalamus
J M Pascual (2014)
Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM
K Heinks (2007)
Epidemiological aspects of craniopharyngioma.
R. Haupt (2006)
The Role of Wnt Signalling in Angiogenesis.
Jun Jun Olsen (2017)
10.1515/JPEM.2006.19.1.15
Health Related Quality of Life and Psychological Outcome in Patients Treated for Craniopharyngioma in Childhood
C.C. Pedreira, (2006)
10.1016/j.metabol.2009.06.031
Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity.
C. Roth (2010)
10.1002/stem.2267
Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma
J. P. Martinez-Barbera (2016)
10.1016/S0360-3016(02)02799-2
Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001.
T. Merchant (2002)
10.1097/00000658-191301000-00015
The pituitary body and its disorders
H. Cushing (1912)
Surgical treatment of craniopharyngiomas in children.
M. Djordjevic (1979)
10.1007/s00381-005-1221-6
Craniopharyngioma: a personal (Boston) experience
R. Scott (2005)
10.1016/J.GDE.2006.12.007
The many ways of Wnt in cancer.
P. Polakis (2007)
10.1016/j.jss.2018.01.029
Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis.
Guoqing Wang (2018)
10.3389/fendo.2011.00081
Long Term Sequelae of Pediatric Craniopharyngioma – Literature Review and 20 Years of Experience
M. Cohen (2011)
10.1530/EJE-17-0707
Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study.
M. Wijnen (2018)
10.1038/ng.2868
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
P. Brastianos (2014)
10.1158/1078-0432.CCR-10-2811
EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas
A. Hoelsken (2011)
10.1093/neuonc/not195
Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
C. Stache (2014)
10.1016/j.jpeds.2013.12.010
Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement.
J. Özyurt (2014)
10.1016/j.ijrobp.2018.01.053
Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
M. Milano (2018)
10.1530/EJE-12-0997
GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases.
F. Zoicas (2013)
10.3171/2015.6.JNS141883
Origin of craniopharyngiomas: implications for growth pattern, clinical characteristics, and outcomes of tumor recurrence.
Yun Bao (2016)
10.3171/PED.2005.103.4.0302
Quality of life and behavioral follow-up study of pediatric survivors of craniopharyngioma.
S. Sands (2005)
10.1016/j.beem.2017.03.003
Sex steroids and the GH axis: Implications for the management of hypopituitarism.
V. Birzniece (2017)
10.3171/2016.9.FOCUS16315
Management and outcome of recurrent adult craniopharyngiomas: an analysis of 42 cases with long-term follow-up.
M. Turel (2016)
10.1093/neuonc/nox123
Intracystic interferon-alpha in pediatric craniopharyngioma patients.
S. Cavalheiro (2017)
10.1111/bpa.12502
Proteomics in pediatric cystic craniopharyngioma
L. Massimi (2017)
10.1111/j.1365-2265.2004.02196.x
High prevalence of long‐term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma
A. Pereira (2005)
10.1111/j.1365-2265.2007.02754.x
Clinical insights into adipsic diabetes insipidus: a large case series
R. Crowley (2007)
10.1210/jc.2012-3928
Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity.
É. Elowe-Gruau (2013)
10.1126/stke.4162007pe70
Type I Interferons as Anti-Inflammatory Mediators
E. Benveniste (2007)
10.1007/s11102-016-0784-4
Adipsic diabetes insipidus in adult patients
M. Cuesta (2016)
10.3171/2013.6.JNS122259
Endoscopic endonasal surgery for craniopharyngiomas: surgical outcome in 64 patients.
M. Koutourousiou (2013)
10.3389/fendo.2012.00039
Intracystic Therapies for Cystic Craniopharyngioma in Childhood
U. Bartels (2012)
10.1007/s11102-015-0663-4
Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
S. Aylwin (2015)
10.1002/1097-0142(1955)8:3<623::AID-CNCR2820080328>3.0.CO;2-D
Squamous‐cell nests of the pituitary gland
S. Luse (1955)
10.1007/s00701-017-3311-0
Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy
E. Rostami (2017)
10.3171/JNS.2000.92.6.1028
Resection of suprasellar tumors by using a modified transsphenoidal approach. Report of four cases.
J. Kouri (2000)
10.1007/s11060-011-0540-6
Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults
E. H. Nielsen (2011)
10.1053/META.2002.35591
Triiodothyronine supplementation for hypothalamic obesity.
J. Fernandes (2002)
10.3389/fendo.2011.00060
Hypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and Treatment
R. Lustig (2011)
10.1182/BLOOD-2016-07-418434
BRAF V600E mutation in hairy cell leukemia: from bench to bedside.
B. Falini (2016)
10.1210/JCEM.87.5.8494
Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
G. Johannsson (2002)
10.1001/jama.1996.03530430066046
Brain Tumors: An Encyclopedic Approach
J. Adams (1996)
10.1017/S0022215110002938
Nasal craniopharyngioma: case report and literature review.
J. Magill (2011)
10.3171/JNS.1990.73.4.0534
Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy.
E. G. Fischer (1990)
10.1016/j.jocn.2011.09.033
Impact of maximal safe resection on the clinical outcome of adults with craniopharyngiomas
M. Lee (2012)
10.1016/j.jocn.2012.04.014
Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: Involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R)
Q. Li (2013)
10.1007/s00401-018-1830-2
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target
J. Apps (2018)
Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University
M Caldarelli (2005)
Craniopharyngiomes simulant une tumeur antérieure du III ventricule
B Pertuiset (1962)
Postoperative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up
H L Muller (2011)
Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up
H L Muller (2008)
10.1227/01.NEU.0000333791.29091.83
Transsphenoidal Approaches for the Extracapsular Resection of Midline Suprasellar and Anterior Cranial Base Lesions
G. Kaptain (2008)
10.1016/j.wneu.2019.06.037
Is gross total resection reasonable in adults with craniopharyngiomas with hypothalamic involvement ?
C. Apra (2019)
10.1038/nrn3901
The connectomics of brain disorders
A. Fornito (2015)
10.1007/s12672-010-0041-7
CTNNB1 Gene Mutations, Pituitary Transcription Factors, and MicroRNA Expression Involvement in the Pathogenesis of Adamantinomatous Craniopharyngiomas
M. L. Campanini (2010)
10.1002/1097-0142(19810301)47:5<847::AID-CNCR2820470505>3.0.CO;2-W
Treatment results of craniopharyngiomas
D. I. Sung (1981)
10.7326/0003-4819-6-10-1347_2
Papers relating to the pituitary body, hypothalamus and parasympathetic nervous system
H. Cushing (1932)
10.1159/000110612
Hypopituitarism Oddities: Craniopharyngiomas
N. Karavitaki (2007)
Hypothalamic obesity: causes, consequences, treatment.
R. Lustig (2008)
10.1007/s12020-016-1159-3
Mortality in adults with hypopituitarism: a systematic review and meta-analysis
S. Jasim (2016)
10.1111/cen.13929
Management of hypothalamic disease in patients with craniopharyngioma
C. Thompson (2019)
10.1002/elps.201300578
Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC‐MS top‐down/bottom‐up integrated approaches
C. Martelli (2014)
10.1097/00000658-191807000-00002
VENTRICULOGRAPHY FOLLOWING THE INJECTION OF AIR INTO THE CEREBRAL VENTRICLES
W. Dandy (1918)
10.1016/s0002-9610(32)90942-8
Intracranial tumours : notes upon a series of two thousand verified cases with surgical-mortality percentages pertaining thereto
H. Cushing (1932)
10.1080/09084282.2010.523394
Brief Communication: Cognitive Rehabilitation of Executive Functioning in a Case of Craniopharyngioma
C. Metzler-Baddeley (2010)
Clinical outcome in children with recurrent craniopharyngioma after primary surgery.
J. Kalapurakal (2000)
10.1016/S0360-3016(02)02965-6
External beam irradiation of craniopharyngiomas: long-term analysis of tumor control and morbidity.
J. Varlotto (2002)
10.1210/jc.2011-2817
Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients.
A. Gautier (2012)
10.1016/j.clineuro.2015.05.019
Association of pituitary stalk management with endocrine outcomes and recurrence in microsurgery of craniopharyngiomas: A meta-analysis
K. Li (2015)
10.3171/2010.2.FOCUS09311
The role of radiosurgery in the treatment of craniopharyngiomas.
A. Veeravagu (2010)
10.1210/jc.2018-00229
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
S. Bhasin (2018)
10.1007/s11102-018-0890-6
Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview
R. Prieto (2018)
10.3390/ijms19030893
Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks
J. Díez (2018)
Neuropsychological assessment, 5th ed.
M. Lezak (2012)
10.3171/JNS.1997.87.1.0044
Endoscopic endonasal transsphenoidal surgery: experience with 50 patients.
H. D. Jho (1997)
10.1016/0360-3016(95)00175-X
Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results.
B. Pollock (1995)
10.3171/JNS.1983.59.3.0409
Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children.
V. Cavazzuti (1983)
10.1007/s00381-005-1205-6
Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood
A. Pierre-Kahn (2005)
10.1097/01.CNE.0000532776.24542.73
Craniopharyngiomas in Adults: Part II—Treatment
G. Guinto (2018)
10.1227/00006123-200209000-00016
Endoscopic Transsphenoidal Approach: Adaptability of the Procedure to Different Sellar Lesions
E. de Divitiis (2002)
10.1002/ANA.410230608
Prospective intellectual testing in children with brain tumors
P. Duffner (1988)
10.3171/2010.8.PEDS09385
Surgical management of giant pediatric craniopharyngiomas.
R. Elliott (2010)
10.1007/s00428-015-1798-4
Jakob Erdheim (1874–1937): father of hypophyseal-duct tumors (craniopharyngiomas)
J. M. Pascual (2015)
10.3171/2017.1.JNS162719
Korsakoff syndrome from retrochiasmatic suprasellar lesions: rapid reversal after relief of cerebral compression in 4 cases.
Luis E. Savastano (2018)
10.1210/jc.2014-3525
Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.
Daniel S Olsson (2015)
10.1007/s11102-012-0451-3
Acute presentation of craniopharyngioma in children and adults in a Danish national cohort
E. H. Nielsen (2012)
10.1002/lary.21162
Nasoseptal flap takedown and reuse in revision endoscopic skull base reconstruction
A. Zanation (2011)
10.1159/000121200
Neurobehavioral outcome in pediatric craniopharyngioma.
C. Anderson (1997)
10.1093/IJE/23.3.458
International incidence of childhood brain and spinal tumours.
C. Stiller (1994)
Pathologies hypophysaires: quels tests utiliser? MCED
P Chanson (2016)
10.3171/2016.9.FOCUS16325
Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
J. C. Martinez-Gutierrez (2016)
10.1093/jnen/nlw116
Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma
T. Goschzik (2017)
10.1515/jpem-2014-0425
Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience
M. Kalina (2015)
10.1007/s11060-018-2762-3
Long-term visual outcomes of craniopharyngioma in children
M. Wan (2018)
10.1136/jnnp.34.1.37
Craniopharyngiomas—a summary of 85 cases
J. Bartlett (1971)
10.1210/jc.2012-1616
Clinical review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges.
L. Persani (2012)
10.3171/JNS.1990.73.1.0012
Correlation of clinical and pathological features in surgically treated craniopharyngiomas.
T. E. Adamson (1990)
10.3238/ARZTEBL.2019.0321
The Postopera tive Quality of Life in Children and Adolescents with Craniopharyngioma.
M. Eveslage (2019)
10.1007/s11102-008-0096-4
Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans
M. Lee (2008)
10.1159/000120867
Treatment of craniopharyngiomas: the multimodality approach.
E. Backlund (1994)
10.1007/s11060-015-1885-z
A systematic review of cognitive performance in patients with childhood craniopharyngioma
J. Özyurt (2015)
10.1159/000339469
Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor
J. Simmons (2012)
10.3171/JNS.2002.97.1.0003
Craniopharyngioma in adults and children: a study of 122 surgical cases.
R. van Effenterre (2002)
10.3171/2016.1.FocusVid.15440
Using the trans-lamina terminalis route via a pterional approach to resect a retrochiasmatic craniopharyngioma involving the third ventricle.
A. Weil (2016)
10.1093/neuonc/not026
Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011.
M. Cohen (2013)
10.1055/S-2008-1052019
Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS).
P. Cappabianca (1998)
10.1093/NEUROSURGERY/27.CN_SUPPL_1.169
Craniopharyngiomas: transsphenoidal method of approach--for the virtuoso only?
I. Ciric (1980)
10.1530/EJE-13-0418
Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist.
S. Shalet (2013)
10.1210/JC.2002-021180
Risk factors for the development of obesity in children surviving brain tumors.
R. Lustig (2003)
10.1016/0306-4530(77)90006-3
Postsurgical IQ and behavioral data on twenty patients with a history of childhood craniopharyngioma
R. Clopper (1977)
10.1055/s-2003-812538
Endoscopic endonasal skull base surgery: Part 1--The midline anterior fossa skull base.
H-D Jho (2004)
Bucopharyngeal membrane
10.1055/S-2007-985848
First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity.
H. Müller (2007)
10.1111/neup.12030
Craniopharyngiomas with a mixed histological pattern: the missing link to the intriguing pathogenesis of adamantinomatous and squamous‐papillary varieties?
R. Prieto (2013)
10.1111/j.1467-789X.2012.01004.x
Hypothalamic obesity in children
A. Bereket (2012)
10.1016/0360-3016(89)90543-9
The role of radiation therapy in the management of childhood craniopharyngioma.
M. Weiss (1989)
10.1530/EJE-15-0422
Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma.
A. Hoffmann (2015)
10.1016/j.jcjo.2013.05.001
Retinal NFL thinning on OCT correlates with visual field loss in pediatric craniopharyngioma.
Omer Y. Bialer (2013)
10.1016/j.ando.2016.05.002
Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay.
V. Raverot (2016)
Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
S. Sekine (2002)
10.1016/j.ijrobp.2009.07.1693
Radiosurgery for craniopharyngioma.
A. Niranjan (2010)
10.1093/ons/opy356
Expanded Endonasal Endoscopic Surgery in Suprasellar Craniopharyngiomas: A Retrospective Analysis of 43 Surgeries Including Recurrent Cases.
I. Radovanovic (2019)
10.1007/s00701-010-0940-y
Anatomic relations of the arachnoidea around the pituitary stalk: relevance for surgical removal of craniopharyngiomas
Songtao Qi (2010)
10.1016/j.wneu.2017.11.012
Preoperative Assessment of Craniopharyngioma Adherence: Magnetic Resonance Imaging Findings Correlated with the Severity of Tumor Attachment to the Hypothalamus.
R. Prieto (2018)
Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients.
H. Müller (2006)
10.1055/S-2006-942249
Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma.
H. Müller (2006)
10.1093/qjmed/hcv175
Heterogenous patterns of recovery of thirst in adult patients with adipsic diabetes insipidus.
M. Cuesta (2016)
10.1016/j.wneu.2017.12.177
Anterior Skull Base Tumor Resection by Transciliary Supraorbital Keyhole Craniotomy: A Single Institutional Experience.
Ya-Jui Lin (2018)
10.1177/1758834015616934
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
Z. Eroglu (2016)
10.1016/J.RADONC.2005.04.015
Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma.
L. Pemberton (2005)
10.1002/cncr.10281
Angiogenesis in patients with craniopharyngiomas
S. Vidal (2002)
10.1016/j.wneu.2017.07.075
Antibiotic Prophylaxis in Endoscopic Endonasal Pituitary and Skull Base Surgery.
L. Milanese (2017)
10.1159/000120863
Transsphenoidal removal of craniopharyngioma.
E. Laws (1994)
10.1111/j.1365-2265.2005.02231.x
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long‐term follow‐up
N. Karavitaki (2005)
10.3171/JNS.1995.83.2.0206
Papillary craniopharyngioma: a clinicopathological study of 48 cases.
T. Crotty (1995)
10.1210/jc.2014-2476
Central hypoadrenalism.
R. Crowley (2014)
10.1210/JCEM-42-2-370
Craniopharyngioma: the role of insulin in promoting postoperative growth.
G. Costin (1976)
10.3171/JNS.1977.47.2.0218
Management of craniopharyngioma in children.
H. Hoffman (1977)
10.1055/S-0038-1633669
Suprasellar and Recurrent Pediatric Craniopharyngiomas: Expanding Indications for the Extended Endoscopic Transsphenoidal Approach
A. Alalade (2018)
10.1016/j.jocn.2011.03.028
The therapeutic efficacy of fractionated radiotherapy and gamma-knife radiosurgery for craniopharyngiomas
Chiman Jeon (2011)
10.1097/MOP.0b013e3282495a22
Craniopharyngioma: modern concepts in pathogenesis and treatment
M. Garrè (2007)
Bariatric surgery following treatment for craniopharyngioma : a systematic review and individual-level data meta-analysis
M. Bretault (2014)
10.3233/BEN-1988-1107
Altered behavior associated with damage to the ventromedial hypothalamus: a distinctive syndrome.
F. Flynn (1988)
10.3171/2015.3.JNS142254
Comparative analysis of outcomes following craniotomy and expanded endoscopic endonasal transsphenoidal resection of craniopharyngioma and related tumors: a single-institution study.
Sunil Jeswani (2016)
These markers could help to understand and predict the biological behaviour of CPs and hopefully be targets for chemotherapy
10.1017/S0012162204000374
Outcome of craniopharyngioma in children: long-term complications and quality of life.
A. Poretti (2004)
10.1093/neuonc/noy035
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma
S. Coy (2018)
10.1007/s11102-018-0903-5
Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma
M. Losa (2018)
10.1210/JCEM.87.2.8193
Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma.
C. Schöfl (2002)
10.1038/NCPENDMET0579
Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy
T. Inge (2007)
10.1227/01.NEU.0000157027.80293.C7
Frontobasal Interhemispheric Trans-Lamina Terminalis Approach for Suprasellar Lesions
A. Dehdashti (2005)
10.1016/J.PEDIATRNEUROL.2005.06.002
Everyday cognitive function after craniopharyngioma in childhood.
D. Waber (2006)
Body Mass Index variations: centiles from birth to 87 years.
M. Rolland-Cachera (1991)
10.1007/s10072-015-2269-z
Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis
L. Shen (2015)
Surgical treatment of craniopharyngiomas.
M. Samii (1991)
10.1007/BF01401137
Pathological characteristics of surgically removed craniopharyngiomas: Analysis of 131 cases
G. T. Szeifert (2005)
10.1016/j.wneu.2017.02.115
Craniopharyngioma: Surgical Outcome as Related to the Degree of Hypothalamic Involvement.
R. Prieto (2017)
10.1007/s10143-018-1010-9
Craniopharyngioma adherence: a reappraisal of the evidence
R. Prieto (2018)
10.3389/fgene.2018.00049
Rathke's Cleft Cyst as Origin of a Pediatric Papillary Craniopharyngioma
Sven-Martin Schlaffer (2018)
10.1007/s12020-016-1047-x
Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients
U. Feldt-Rasmussen (2016)
10.1016/j.beem.2017.02.004
Controversies in the risk of neoplasia in GH deficiency.
S. Pekić (2017)
10.1515/JPEM.2006.19.2.129
Dexamphetamine Use for Management of Obesity and Hypersomnolence Following Hypothalamic Injury
D. Ismail (2006)
10.1212/WNL.35.12.1731
Severe disturbance of higher cognition after bilateral frontal lobe ablation
P. Eslinger (1985)
10.1038/nrendo.2016.217
New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma
H. Müller (2017)
10.1016/j.endinu.2016.10.006
Hypothalamic obesity after craniopharyngioma surgery: Treatment with a long acting glucagon like peptide 1 derivated.
I. Castro-Dufourny (2017)
10.1007/s00381-009-1078-1
Energy expenditure in obesity associated with craniopharyngioma
Roy J. Kim (2009)
Craniopharyngioma in adults.
M. Banna (1973)
10.1002/pbc.26936
Hypothalamic involvement in craniopharyngioma—Implications for surgical, radiooncological, and molecularly targeted treatment strategies
H. Müller (2018)
10.1227/00006123-198711000-00006
Factors affecting intellectual outcome in pediatric brain tumor patients.
L. Ellenberg (1987)
10.1111/j.1440-1789.2011.01235.x
Coexistence of adamantinomatous and squamous‐papillary type craniopharyngioma: Case report and discussion of etiology and pathology
Tomu Okada (2012)
10.1111/j.1365-2559.2004.02029.x
Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation
S. Sekine (2004)
10.3171/2013.3.JNS122214
Molecular oncogenesis of craniopharyngioma: current and future strategies for the development of targeted therapies.
I. Hussain (2013)
10.23736/S0390-5616.17.04171-6
Treatment strategies for craniopharyngiomas.
M. Ottenhausen (2019)
10.3171/2016.9.FOCUS16317
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas.
M. Zoli (2016)
10.1016/j.radonc.2018.05.001
Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus.
M. Lambrecht (2018)
10.1177/2042018816687240
Current best practice in the management of patients after pituitary surgery
A. Prete (2017)
10.3171/2016.9.FOCUS16304
Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors.
R. Prieto (2016)
10.3174/ajnr.A5361
Topographic Diagnosis of Craniopharyngiomas: The Accuracy of MRI Findings Observed on Conventional T1 and T2 Images
R. Prieto (2017)
10.3171/2008.10.JNS0880
Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation.
T. Jung (2009)
Hypopituitarism (Internet). The pituitary society
P M Stewart
10.1007/s11060-013-1284-2
Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach
J. Kilday (2013)
10.3171/PED/2008/1/2/126
Long-term outcome in children treated for craniopharyngioma with and without radiotherapy.
L. Lin (2008)
Manual for the Child: Behavior Checklist and Revised Child Behavior Profile
T. M. Achenbach (1983)
10.1001/JAMA.1983.03330300091055
Surgical Pathology of the Nervous System and Its Coverings
J. Chason (1983)
Radical resection for craniopharyngiomas in children: surgical technique and clinical results.
P. Dhellemmes (2006)
10.1016/0090-3019(93)90223-N
Spontaneous rupture of craniopharyngioma cysts. A report of five cases and review of the literature.
H. Satoh (1993)
10.1097/00000441-193404000-00020
Benign tumors in the third ventricle of the brain : diagnosis and treatment
W. Dandy (1934)
10.3171/FOC.2005.19.1.4
Expanded endonasal approach: the rostrocaudal axis. Part I. Crista galli to the sella turcica.
A. Kassam (2005)
10.1016/J.IJROBP.2005.09.034
Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital.
M. Fitzek (2006)
10.1111/bpa.12501
Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biology
J. Apps (2017)
10.1016/j.wneu.2017.11.004
Neuroendoscopic Treatment of Cystic Craniopharyngiomas: A Case Series with Systematic Review of the Literature.
L. Lauretti (2018)
10.1002/jcb.28253
CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway
X. Yin (2019)
10.1016/B978-0-12-416021-7.00001-8
Pituitary gland development and disease: from stem cell to hormone production.
S. Davis (2013)
10.3892/IJMM.14.4.505
Expression of interleukin-6 in human craniopharyngiomas: a possible inducer of tumor-associated inflammation.
Masanao Mori (2004)
10.1515/JPEM.2009.22.9.867
Outcome after Bariatric Surgery in Two Adolescents with Hypothalamic Obesity Following Treatment of Craniopharyngioma
D. Rottembourg (2009)
10.1055/S-2003-42722
Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain.
H. Müller (2003)
10.3171/2017.11.JNS172373
Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report.
Benjamin T Himes (2018)
10.3171/JNS.2001.94.6.0999
Extended transsphenoidal approach with submucosal posterior ethmoidectomy for parasellar tumors. Technical note.
M. Kitano (2001)
10.1210/JC.2003-030442
Features of the metabolic syndrome after childhood craniopharyngioma.
S. Srinivasan (2004)
10.1055/S-2003-39789
Volumetric bone mineral density in patients with childhood craniopharyngioma.
H. Müller (2003)
10.1007/s11102-011-0294-3
Objective assessment of thirst recovery in patients with adipsic diabetes insipidus
A. Sinha (2011)
10.1176/JNP.4.1.45
Hypothalamic lesions and intermittent explosive disorder.
J. Tonkonogy (1992)
10.1016/j.wneu.2017.07.138
Anatomic Dissection of Arachnoid Membranes Encircling the Pituitary Stalk on Fresh, Non-Formalin-Fixed Specimens: Anatomoradiologic Correlations and Clinical Applications in Craniopharyngioma Surgery.
P. Ciappetta (2017)
10.1016/j.nlm.2014.03.007
Remote effects of hypothalamic lesions in the prefrontal cortex of craniopharygioma patients
J. Özyurt (2014)
10.5167/UZH-1853
MR differentiation of adamantinous and squamous-papillary craniopharyngiomas.
S. Sartoretti-Schefer (1997)
10.1530/EJE-12-1082
Autonomic nervous system balance in children and adolescents with craniopharyngioma and hypothalamic obesity.
M. Cohen (2013)
10.1007/s00381-016-3050-1
Ectopic recurrence of pediatric craniopharyngiomas after gross total resection: a report of two cases and a review of the literature
C. Du (2016)
10.1016/S0360-3016(98)00257-0
Craniopharyngioma in children.
Y. Khafaga (1998)
10.1210/er.2018-00017
Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.
Laura van Iersel (2019)
10.1097/00006123-199412000-00001
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
H. Weiner (1994)
10.1016/j.cortex.2013.12.005
Limbic systems for emotion and for memory, but no single limbic system
E. Rolls (2015)
The roentgenological diagnosis of craniopharyngeal pouch tumors
K G Mckenzie (1924)
Le craniopharyngiome de l'enfant
M Choux (1991)
10.1055/s-0036-1588060
Pathological and Topographical Classification of Craniopharyngiomas: A Literature Review
James Lubuulwa (2016)
10.1016/j.clineuro.2007.10.013
Craniopharyngioma: Surgical experience of 309 cases in China
X. Shi (2008)
10.3171/2014.7.FOCUS14317
Expanding indications for the extended endoscopic endonasal approach to hypothalamic gliomas: preliminary report.
M. Zoli (2014)
10.1016/j.wneu.2018.05.126
Quantitative Anatomic Analysis of the Transcallosal-Transchoroidal Approach and the Transcallosal-Subchoroidal Approach to the Floor of the Third Ventricle: An Anatomic Study.
Baran Bozkurt (2018)
10.1016/j.clineuro.2018.04.009
Endocrine outcomes of endoscopic versus transcranial resection of craniopharyngiomas: A system review and meta-analysis
Nidan Qiao (2018)
10.1097/00006123-200212000-00013
Tuberculum sellae meningiomas: microsurgical anatomy and surgical technique.
G. Jallo (2002)
10.1007/s11102-012-0428-2
Mortality and morbidity in adult craniopharyngioma
E. Erfurth (2012)
10.1080/02688690310001601207
Psychiatric, cognitive and behavioural outcomes following craniopharyngioma and pituitary adenoma surgery
J. Bellhouse (2003)
10.1002/1098-2353(200101)14:1<1::AID-CA1000>3.0.CO;2-3
Expanding the boundaries of the transsphenoidal approach: A microanatomic study
A. Romano (2001)
10.1210/jc.2009-2003
Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls.
C. O'Gorman (2010)
10.1227/NEU.0000000000000380
Malignant transformation in craniopharyngiomas.
A. Sofela (2014)
10.1016/S0360-3016(03)01570-0
Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults.
D. Stripp (2004)
10.1016/j.clineuro.2006.01.007
Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas
M. Tena-Suck (2006)
10.1097/00006123-199711000-00031
Craniopharyngiomas in two consanguineous siblings: case report.
A. L. Boch (1997)
10.1056/NEJMoa1308573
A randomized trial of bevacizumab for newly diagnosed glioblastoma.
M. Gilbert (2014)
10.1080/02688699844790
Primary transsphenoidal microsurgery in the treatment of craniopharyngiomas.
J. Norris (1998)
10.1159/000338695
Functional Neuroimaging in Craniopharyngioma: A Useful Tool to Better Understand Hypothalamic Obesity?
C. Roth (2012)
10.1210/JC.2002-021797
Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity.
K. Harz (2003)
10.1007/s00381-005-1202-9
Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital
T. Tomita (2005)
10.1371/journal.pone.0076562
Prevalence of Neurobehavioral, Social, and Emotional Dysfunction in Patients Treated for Childhood Craniopharyngioma: A Systematic Literature Review
G. Zada (2013)
10.1530/EJE-11-0158
Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up.
H. Müller (2011)
10.1007/s11102-013-0543-8
Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?
A. Hoelsken (2013)
10.1007/s00381-005-1166-9
Functional capacity and body mass index in patients with sellar masses—cross-sectional study on 403 patients diagnosed during childhood and adolescence
H. Müller (2005)
10.1007/s00381-005-1190-9
The pathogenesis of craniopharyngiomas
V. Prabhu (2005)
10.1016/S0140-6736(15)60898-4
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
G. Long (2015)
10.1093/jnen/nlx061
Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma
A. Donson (2017)
10.1016/j.wneu.2013.02.011
Primary adult infradiaphragmatic craniopharyngiomas: clinical features, management, and outcomes in one Chinese institution.
Liang Wang (2014)
10.1111/nyas.14027
The Wnt signaling pathway: a potential therapeutic target against cancer
Noyel Ghosh (2019)
10.1210/jc.2017-02080
Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection
Eugenie Hsu (2018)
10.1055/s-0038-1625940
Endoscopic Endonasal Transplanum Transtuberculum Approach for the Resection of a Large Suprasellar Craniopharyngioma
J. Mangussi-Gomes (2018)



Semantic Scholar Logo Some data provided by SemanticScholar